Jim Cramer Says “Merck Is Terrific”

robot
Abstract generation in progress

Jim Cramer endorsed Merck & Co., Inc. (NYSE:MRK), calling it “terrific” despite a rotation out of healthcare stocks. He noted its 13 times earnings valuation and suggested buying strategy for potential dips. TCW Relative Value Large Cap Fund also highlighted Merck’s strong performance in Q4 2025 due to cost-cutting and strong vaccine sales, although they suggest AI stocks may offer greater upside.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin